Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kura Oncology (NQ: KURA ) 20.95 -0.55 (-2.56%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Kura Oncology Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies June 17, 2024 EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:SNDX),(NASDAQ:KURA),(NASDAQ:BMEA),(NYSE:JNJ) EQNX::TICKER_END Via FinancialNewsMedia Kura Oncology Inc. (NASDAQ: KURA) is a Stock Spotlight on 3/6 March 06, 2024 Via Investor Brand Network Kura Oncology Inc. (NASDAQ: KURA) Near the Top of Equities by Percentage Gain on 1/24 January 24, 2024 Via Investor Brand Network 7 Best Cancer Stocks to Invest in Now July 28, 2023 The second-largest cause of death in the U.S., more than 600,000 deaths from cancer will occur in 2023. Learn about the best cancer stocks to invest in now. Via MarketBeat Topics Death Exposures Death Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies June 17, 2024 From FN Media Group LLC Via GlobeNewswire Kura Oncology, Inc. (NASDAQ:KURA) Investor Notice: Investigation over Potential Wrongdoing March 04, 2022 San Diego, CA -- (SBWIRE) -- 03/04/2022 -- Certain directors of Kura Oncology, Inc are under investigation over potential breaches of fiduciary duties. Via SBWire Groundbreaking Clinical Trials Accelerating New Treatment Options for Pancreatic Cancer February 02, 2022 Palm Beach, FL – February 2, 2022 – FinancialNewsMedia.com News Commentary – In the battle against pancreatic cancer, new and innovative clinical trials have become extremely critical. These trials... Via FinancialNewsMedia NASDAQ:KURA Investor Notice: Investigation over Possible Securities Laws Violations by Kura Oncology, Inc. December 09, 2021 San Diego, CA -- (SBWIRE) -- 12/09/2021 -- Kura Oncology, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. Via SBWire Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.